Back to Search
Start Over
273P Talazoparib (TALA) for patients with germline BRCA1/2 mutated (gBRCA1/2mut) advanced breast cancer (ABC): Characteristics of patients who experienced hematologic toxicity in the phase III EMBRACA trial.
- Source :
-
Annals of Oncology . 2021 Supplement 5, Vol. 32, pS482-S482. 1p. - Publication Year :
- 2021
- Subjects :
- *BREAST cancer
*GERM cells
Subjects
Details
- Language :
- English
- ISSN :
- 09237534
- Volume :
- 32
- Database :
- Academic Search Index
- Journal :
- Annals of Oncology
- Publication Type :
- Academic Journal
- Accession number :
- 152688904
- Full Text :
- https://doi.org/10.1016/j.annonc.2021.08.556